REGENERX BIOPHARM IN (OTCMKTS:RGRX) had a decrease of 22.22% in short interest. RGRX’s SI was 7,700 shares in April as released by FINRA. Its down 22.22% from 9,900 shares previously. With 53,100 avg volume, 0 days are for REGENERX BIOPHARM IN (OTCMKTS:RGRX)’s short sellers to cover RGRX’s short positions. It is 0.00% or $0 reaching $0.3 per share. It is down 25.00% since September 7, 2016 and is downtrending. It has underperformed by 32.26% the S&P500.
The stock of Pan American Silver Corp. (USA) (NASDAQ:PAAS) is a huge mover today! About 1.01M shares traded. Pan American Silver Corp. (USA) (NASDAQ:PAAS) has declined 7.19% since September 7, 2016 and is downtrending. It has underperformed by 14.45% the S&P500.The move comes after 5 months positive chart setup for the $2.92B company. It was reported on Apr, 13 by Barchart.com. We have $20.75 PT which if reached, will make NASDAQ:PAAS worth $262.80 million more.
RegeneRx Biopharmaceuticals, Inc. is a biopharmaceutical company. The company has market cap of $32.01 million. The Firm is focused on the development of a therapeutic peptide, Thymosin beta 4 , for tissue and organ protection, repair and regeneration. It currently has negative earnings. The Company’s segment is the development and marketing of product candidates based on Tb4, an amino acid peptide.
Analysts await Pan American Silver Corp. (USA) (NASDAQ:PAAS) to report earnings on May, 10. They expect $0.10 earnings per share, up 400.00% or $0.08 from last year’s $0.02 per share. PAAS’s profit will be $15.32M for 47.65 P/E if the $0.10 EPS becomes a reality. After $0.12 actual earnings per share reported by Pan American Silver Corp. (USA) for the previous quarter, Wall Street now forecasts -16.67% negative EPS growth.
Pan American Silver Corp. is a silver production company. The company has market cap of $2.92 billion. The Firm is principally engaged in the operation and development of, and exploration for, silver producing properties. It has a 29.03 P/E ratio. The Company’s divisions include Peru, Mexico, Argentina and Bolivia.
